Improving Health, Health Care and Quality of Life
The rights are not being distributed in response to any specific effort to acquire DaVita. The rights are designed to assure that DaVita's shareholders receive fair and equal treatment in the event of any proposed takeover of DaVita, and to guard against partial tender offers, open market accumulations and other tactics designed to gain control of DaVita without paying all of DaVita's shareholders a fair price.
If the rights become exercisable each right will entitle its holder to purchase for $125 shares of DaVita common stock having a market value of $250. Rights held by the triggering person will become void and will not be exercisable. If DaVita is acquired in a merger or other business combination transaction after the rights are triggered each right will entitle its holder to purchase for $125 shares of the acquiring company's common stock having a market value of $250.
The dividend distribution will be payable on December 10, 2002 to holders of record of DaVita common stock on November 29, 2002. The rights will expire in ten years. The rights distribution is not taxable to DaVita stockholders.
DaVita is a leading provider of dialysis services for patients suffering from chronic kidney failure. The Company owns and operates kidney dialysis centers and home peritoneal dialysis programs domestically in 32 states, as well as Washington, D.C. As of September 30, 2002, DaVita operated 504 outpatient dialysis facilities serving over 44,000 patients, including 3,300 patients in 29 centers under management.
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk, 888-776-6555 or 212-782-2840
SOURCE: DaVita Inc.
CONTACT: LeAnne Zumwalt, Investor Relations of DaVita Inc.,
Web site: http://www.davita.com/